Overcoming Barriers to Maternal Immunization for the Prevention of Respiratory Syncytial Virus Disease in Minoritized and Marginalized Communities
Post-Test/Evaluation

Questions marked with a * are required

60%

Contact Information

First Name

Last Name

Email Address

Credentials/Degree (MD, DO, RN, etc.)

Date of Participation

What are some of the risk factors for severe RSV infection among children?

Immunocompromise

Exposure to cigarette smoke in utero

Low socioeconomic status

Premature birth

All of the above

The RSVpreF vaccine currently available for pregnant women can prevent severe RSV disease in infants. Which of the following describes the best time to administer the vaccine for pregnant women living in most states of the US [Note that RSV seasons can vary in different parts of the US]?

Weeks 28 and 32 weeks, September through January

Weeks 32 to 36 weeks, any time of the year

Weeks 32 to 36 weeks, September through January

Any time during the third trimester, any time of the year

Olivia is a 19-year-old woman at 30 weeks gestational age of her first pregnancy. She has taken the Tdap, influenza and COVID vaccines so far. She believes that excessive vaccination could pose a threat to her unborn child. Moreover she believes that as it is now December, it is almost the end flu season and so a vaccine is not really required. How would you address her hesitancy?

Educate her on RSV vaccine risks and benefits, dispel misconceptions about RSV disease, and encourage her to take the RSV vaccine between 32 and 36 weeks of gestation in order to protect her unborn child

Review CDC guidance regarding the prevention of RSV

Acknowledge that there is no long-term data on the RSV vaccine and ask her to take precautions to avoid RSV disease

None of the above

What is your job role?

OB/GYN

Family Medicine Physicians

Maternal-Fetal Medicine Specialists

Nurse Midwives

Doulas

Community Health Workers

Patient Navigators

Nurse Practitioners

Physician Assistants

Other

What is your type of practice?

Hospital

Community/Private

Clinic

Academic

HMO/MCO

Other

How many years have you been in practice?

Fewer than 5

5 to 9

10 to 15

More than 15

N/A

Please estimate the number of patients with RSV that you treat each month:

1-10

11-25

26-50

51-75

> 75

N/A

Were the following learning objectives met?

	Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
Assess the burden of disease associated with RSV disease in infants, pregnant women, and on healthcare systems	Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree

Evaluate the benefits associated with maternal immunizations including emerging RSV vaccines	Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree

Incorporate strategies to overcome barriers to maternal immunization for the prevention of RSV	Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree

Please rate your confidence in your ability to evaluate data regarding targeted treatments for patients with RSV on a scale of 1 to 5, where 1 means "not confident at all," and 5 means "very confident."

	1	2	3	4	5
Confidence	1	2	3	4	5

As a result of this course, I will likely make changes to my practice.

Yes

N/A

If YES, in which of the following categories? (Please check all that apply)

Use of RSV vaccines for maternal immunizations

Patient Safety

Coordination of Care

Patient Communication/Patient Education

In particular, as a result of this course, I will be more likely to implement the following changes:
(Please check all that apply)

Understand and explain to patients the benefits associated with maternal immunizations with RSV vaccines

Explain the burden of RSV disease in infants, pregnant women, and on healthcare systems

Incorporate strategies that will help overcome barriers to maternal RSV vaccine immunization

Additionally, I will change: